Samrat Pharmachem Limited

SAMRATPH6

INE103E01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:01:02 05/07/2024 BST			5-day change	1st Jan Change
338.8 ^INR	+0.83%		+0.04%	-2.69%

07-04	Samrat Pharmachem Limited Announces Director Resignations	CI
02-29	Crisil Gives BB+ Rating to Samrat Pharmachem's Bank Loans; Outlook Stable	MT

Samrat Pharmachem Limited Appoints Sandeep Umashankar Prajapati as Company Secretary Cum Compliance Officer

May 16, 2019 at 10:36 am

Samrat Pharmachem Limited announced that Mr. Sandeep Umashankar Prajapati appointed as Company Secretary cum Compliance Officer of the company with effect from March 1, 2019 on the terms and conditions and payment of remuneration as may be decided by the Board from time to time in consultation with the Company Secretary cum Compliance Officer.

Latest news about Samrat Pharmachem Limited

Samrat Pharmachem Limited Announces Director Resignations	07-04	CI
Crisil Gives BB+ Rating to Samrat Pharmachem's Bank Loans; Outlook Stable	02-29	MT
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08	CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Samrat Pharmachem Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23	CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/05/23	CI
Samrat Pharmachem Limited Recommends Dividend for the Financial Year Ended March 31, 2023	30/05/23	CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22	CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	30/05/22	CI
Samrat Pharmachem Limited Recommends Dividend for the Financial Year Ended March 31, 2022	30/05/22	CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	10/02/22	CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	13/11/21	CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	13/08/21	CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	30/06/21	CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	13/02/21	CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	13/11/20	CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	14/09/20	CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	31/07/20	CI
Samrat Pharmachem Limited Announces Company Secretary and Compliance Officer Changes	13/07/20	CI
Samrat Pharmachem Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	14/02/20	CI
Samrat Pharmachem Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/11/19	CI
Samrat Pharmachem Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	18/08/19	CI
Samrat Pharmachem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	30/05/19	CI

Chart Samrat Pharmachem Limited

Duration

Period

More charts

Company Profile

Samrat Pharmachem Limited is an India-based company, which is engaged in the manufacturing and selling of pharmaceutical chemicals. The Company is a supplier of iodine derivatives to the Indian and foreign market. The Companyâs products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. It serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The Company exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SAMRAT PHARMACHEM LIMITED	-2.69%	12.43M
ELI LILLY AND COMPANY	+54.07%	809B
NOVO NORDISK A/S	+39.91%	624B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	319B
ABBVIE INC.	+5.72%	289B
ASTRAZENECA PLC	+14.34%	240B
ROCHE HOLDING AG	+0.82%	219B
NOVARTIS AG	+14.68%	220B
AMGEN INC.	+7.42%	166B